Why the study?
The current evidence base on if, and how, the risk of cardiac events can be modified in non-cardiac surgery is lacking.
A review of current practices and evidence gaps in the assessment and management of ischemic heart disease for patients undergoing non-cardiac surgery.
Review identifies evidence gaps in perioperative IHD management; leaves open optimal strategies for non-cardiac surgery.
In the setting of non-cardiac surgery, cardiac complications contribute to over a third of perioperative deaths. With over 230 million major surgeries performed annually, and an increasing prevalence of cardiovascular risk factors and ischaemic heart disease, the incidence of perioperative myocardial infarction is also rising. The recent European Society of Cardiology guidelines on cardiovascular risk in noncardiac surgery elevated practices aiming to identify those at most risk, including biomarker monitoring and stress testing. However the current evidence base on if, and how, the risk of cardiac events can be modified is lacking. This review focuses on patient, surgical and cardiac risk assessment, as well as exploring the data on perioperative revascularization and other risk-reduction strategies.
No takes yet. Share an insight, caveat, or question.
Morgan et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: